Russian Pediatric Experience on Assessing the Effectiveness of Imiglucerase for Long-Term Enzyme Replacement Therapy of Gaucher Disease Type 1 in Children

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk - Russian Federation
doi 10.15690/vramn792
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Paediatrician Publishers LLC

Related search

Cost-Effectiveness of Enzyme Replacement Therapy for Type 1 Gaucher Disease

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2014English

Psy97 - Cost-Effectiveness Analysis of Enzyme Replacement Therapy for Type 1 Gaucher Disease

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Long-Term Clinical Outcomes in Type 1 Gaucher Disease Following 10 Years of Imiglucerase Treatment

Journal of Inherited Metabolic Disease
Genetics
2012English

Psy51 - Clinical and Economic Aspects of Enzyme Replacement Therapy in Russian Patients With Gaucher Disease Type 1

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Clinical Effectiveness and Cost-Effectiveness of Enzyme Replacement Therapy for Gaucher’s Disease: A Systematic Review

Clinical Governance: An International Journal
2007English

Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I

2019English

PP044 Adherence to Enzyme Replacement Therapy in Gaucher Disease

International Journal of Technology Assessment in Health Care
Health Policy
2017English

Enzyme Replacement in Gaucher Disease

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2004English

Limited Effects of Long-Term Enzyme Replacement Therapy on the Cardiac Conduction System in Fabry Disease

Journal of Cardiology Cases
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy